<VariationArchive VariationID="551367" VariationName="NM_000543.5(SMPD1):c.84del (p.Gly29fs)" VariationType="Deletion" Accession="VCV000551367" Version="11" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-04-06" DateCreated="2018-08-05" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="546338" VariationID="551367">
      <GeneList>
        <Gene Symbol="LOC130005193" FullName="ATAC-STARR-seq lymphoblastoid silent region 3099" GeneID="130005193" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6390191" stop="6390690" display_start="6390191" display_stop="6390690" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SMPD1" FullName="sphingomyelin phosphodiesterase 1" GeneID="6609" HGNC_ID="HGNC:11120" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6390474" stop="6394996" display_start="6390474" display_stop="6394996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6411643" stop="6416227" display_start="6411643" display_stop="6416227" Strand="+" />
          </Location>
          <OMIM>607608</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000543.5(SMPD1):c.84del (p.Gly29fs)</Name>
      <CanonicalSPDI>NC_000011.10:6390677:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6390678" stop="6390678" display_start="6390678" display_stop="6390678" variantLength="1" positionVCF="6390677" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6411908" stop="6411908" display_start="6411908" display_stop="6411908" variantLength="1" positionVCF="6411907" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>G29fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.6390682del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.6390682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.6411912del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.6411912del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011780.1" sequenceAccession="NG_011780" sequenceVersion="1" change="g.5258del">
            <Expression>NG_011780.1:g.5258del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000543.5" sequenceAccession="NM_000543" sequenceVersion="5" change="c.84del" MANESelect="true">
            <Expression>NM_000543.5:c.84del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000534.3" sequenceAccession="NP_000534" sequenceVersion="3" change="p.Gly29fs">
            <Expression>NP_000534.3:p.Gly29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001007593.3" sequenceAccession="NM_001007593" sequenceVersion="3" change="c.84del">
            <Expression>NM_001007593.3:c.84del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001007594.2" sequenceAccession="NP_001007594" sequenceVersion="2" change="p.Gly29fs">
            <Expression>NP_001007594.2:p.Gly29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318087.2" sequenceAccession="NM_001318087" sequenceVersion="2" change="c.84del">
            <Expression>NM_001318087.2:c.84del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305016.1" sequenceAccession="NP_001305016" sequenceVersion="1" change="p.Gly29fs">
            <Expression>NP_001305016.1:p.Gly29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318088.2" sequenceAccession="NM_001318088" sequenceVersion="2" change="c.-878del">
            <Expression>NM_001318088.2:c.-878del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365135.2" sequenceAccession="NM_001365135" sequenceVersion="2" change="c.84del">
            <Expression>NM_001365135.2:c.84del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352064.1" sequenceAccession="NP_001352064" sequenceVersion="1" change="p.Gly29fs">
            <Expression>NP_001352064.1:p.Gly29fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027400.3" sequenceAccession="NR_027400" sequenceVersion="3" change="n.209del">
            <Expression>NR_027400.3:n.209del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_134502.2" sequenceAccession="NR_134502" sequenceVersion="2" change="n.209del">
            <Expression>NR_134502.2:n.209del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="750157176" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000543.5(SMPD1):c.84del (p.Gly29fs) AND Niemann-Pick disease, type A" Accession="RCV000666408" Version="4">
        <ClassifiedConditionList TraitSetID="758">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-11-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.84del (p.Gly29fs) AND Sphingomyelin/cholesterol lipidosis" Accession="RCV001269196" Version="1">
        <ClassifiedConditionList TraitSetID="8114">
          <ClassifiedCondition DB="MedGen" ID="C0028064">Sphingomyelin/cholesterol lipidosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-11-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.84del (p.Gly29fs) AND multiple conditions" Accession="RCV001855459" Version="3">
        <ClassifiedConditionList TraitSetID="9472">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268243">Niemann-Pick disease, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-04" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-08-05" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12369017</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12556236</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15221801</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15241805</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16010684</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23252888</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32375665</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8053910</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
            <Trait ID="3636" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type B</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+B/5227" DB="Genetic Alliance" />
                <XRef ID="39390005" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10729" />
                <XRef ID="10729" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77293" DB="Orphanet" />
              <XRef ID="C0268243" DB="MedGen" />
              <XRef ID="MONDO:0011871" DB="MONDO" />
              <XRef Type="MIM" ID="607616" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8114" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14993" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Niemann-Pick disease</ElementValue>
                <XRef ID="MONDO:0001982" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sphingomyelin/cholesterol lipidosis</ElementValue>
                <XRef ID="Niemann-Pick+disease/5222" DB="Genetic Alliance" />
                <XRef ID="58459009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13334" />
                <XRef ID="13334" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="C0028064" DB="MedGen" />
              <XRef ID="MONDO:0001982" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="758" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1540999" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="25023|OMIM:257200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000790695" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12556236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15241805</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23252888</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8053910</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16010684</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="G" referenceAllele="GC" start="6411907" stop="6411908" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.4:c.84delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2860236" SubmissionDate="2020-12-02" DateLastUpdated="2020-12-07" DateCreated="2020-12-07">
        <ClinVarSubmissionID localKey="NM_000543.4:c.84delC|MedGen:C0028064" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001448494" DateUpdated="2020-12-07" DateCreated="2020-12-07" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23252888</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32375665</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12556236</ID>
          </Citation>
          <Comment>Variant summary: SMPD1 c.84delC (p.Gly29AspfsX48) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2e-05 in 244564 control chromosomes. c.84delC has been reported in the literature in individuals affected with Niemann-Pick Disease Type A (Sikora_2003, Irun_2013, Ordieres-Ortega_2020). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.4:c.84delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Sphingomyelin/cholesterol lipidosis</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0028064" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8677443</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4080684" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000543.5:c.84del|Niemann-Pick Disease, Types A/B" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002091652" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-27">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.84del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Niemann-Pick Disease, Types A/B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7850245" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000543.5:c.84del|OMIM:257200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004205535" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.84del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4254584" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4891001|MedGen:C0268243;C0268242" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002233254" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12369017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15221801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12556236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23252888</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly29Aspfs*48) in the SMPD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMPD1 are known to be pathogenic (PMID: 12369017, 15221801). This variant is present in population databases (rs750157176, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with Neimann-Pick disease (PMID: 12556236, 23252888). ClinVar contains an entry for this variant (Variation ID: 551367). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.6411908del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268243" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268242" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4254584" TraitType="Disease" MappingType="XRef" MappingValue="C0268243" MappingRef="MedGen">
        <MedGen CUI="C0268243" Name="Niemann-Pick disease, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4080684" TraitType="Disease" MappingType="Name" MappingValue="Niemann-Pick Disease, Types A/B" MappingRef="Preferred">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4254584" TraitType="Disease" MappingType="XRef" MappingValue="C0268242" MappingRef="MedGen">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2860236" TraitType="Disease" MappingType="Name" MappingValue="Sphingomyelin/cholesterol lipidosis" MappingRef="Preferred">
        <MedGen CUI="C0028064" Name="Sphingomyelin/cholesterol lipidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1540999" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7850245" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

